FindTrial
Sign In

STUDY COMPARING TWO DRUG USED TO CONTROL HEART RATE AND BLOOD PRESSURE DURING PLACEMENT OF BREATHING TUBE IN SURGERY

Comparison Between Dexmedetomidine And Remifentanil For Attenuation Of Hemodynamic Response To Laryngoscopy And Tracheal Intubation - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104530
Enrollment
210
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Infusion Dexmedetomidine: infusion dexmedetomidine is given at a dose of 1 microgram of body weight over a period of 10 minutes before intubation Intervention2: Infusion Remifentanil: I

Sponsors

Dr Shibani Kairi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA1 AND ASA2

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
to determine and compare effect of dexmedetomidine and reminfentanil in attenuation of haemodynamic response like systolic blood pressure ,heart rate ,saturation in upper abdominal surgery.Timepoint: At baseline—

Secondary

MeasureTime frame
access side effect with dexmedetomidine & remifentanilTimepoint: at baseline—

Countries

India

Contacts

Public ContactDr Suneeta Dutta

Silchar Medical College and Hospital

drsuneetadutta@gmail.com7002826884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026